You're reading the free version. Trader adds the live tape and alerts.
Start tracking
OTLK Buy Disclosure
Sukhtian Faisal Ghiath · SEC Form 4 · Filed Jul 29, 2026
Buy
Calculated transaction value
$100K
Sukhtian Faisal Ghiath Director
OTLK
Outlook Therapeutics
OTLK
Transaction date
Jul 29, 2026
Public filing date
Jul 29, 2026
Filing lag
Filed same day
OTLK daily price context
Close on/before transaction
$1
Jul 29, 2026
First close after public filing
$1
Jul 29, 2026
30-day return after filing
-35.51%
Through Aug 28, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 95,398 shares @ $1.05
- SEC ownership
- Direct
- Transaction code
- P
- Form
- 4
- Filing identifier
- 0001649989-26-000008
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$100K
Buys / sales
1 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Outlook Therapeutics, Inc. OTLK Current | Buy | Jul 29, 2026 | $100K |